Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
2.41%
operating margin TTM
3.95%
revenue TTM
28.88 Million
revenue per share TTM
0.29$
valuation ratios | |
|---|---|
| pe ratio | 431.08 |
| peg ratio | 0.66 |
| price to book ratio | 21.39 |
| price to sales ratio | 10.72 |
| enterprise value multiple | 184.80 |
| price fair value | 21.39 |
profitability ratios | |
|---|---|
| gross profit margin | 95.49% |
| operating profit margin | 3.95% |
| pretax profit margin | 0.86% |
| net profit margin | 2.41% |
| return on assets | 2.39% |
| return on equity | 5.44% |
| return on capital employed | 5.71% |
liquidity ratios | |
|---|---|
| current ratio | 2.76 |
| quick ratio | 2.37 |
| cash ratio | 1.28 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 975.77 |
| operating cycle | 1,053.97 |
| days of payables outstanding | 513.54 |
| cash conversion cycle | 540.43 |
| receivables turnover | 4.67 |
| payables turnover | 0.71 |
| inventory turnover | 0.37 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.19 |
| debt equity ratio | 0.38 |
| long term debt to capitalization | 0.26 |
| total debt to capitalization | 0.28 |
| interest coverage | 1.12 |
| cash flow to debt ratio | 0.74 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.28 |
| cash per share | 0.94 |
| operating cash flow per share | 0.29 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.74 |
| short term coverage ratios | 37.47 |
| capital expenditure coverage ratio | 144.58 |
Frequently Asked Questions
When was the last time Avadel Pharmaceuticals plc (NASDAQ:AVDL) reported earnings?
Avadel Pharmaceuticals plc (AVDL) published its most recent earnings results on 04-11-2025.
What is Avadel Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Avadel Pharmaceuticals plc (NASDAQ:AVDL)'s trailing twelve months ROE is 5.44%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Avadel Pharmaceuticals plc (AVDL) currently has a ROA of 2.39%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AVDL's net profit margin stand at?
AVDL reported a profit margin of 2.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AVDL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.76 in the most recent quarter. The quick ratio stood at 2.37, with a Debt/Eq ratio of 0.38.